APA

Rübsamen-Waigmann H., Huguenel E., Shah A., Paessens A., Ruoff H. J., von Briesen H., Immelmann A., Dietrich U. & Wainberg M. A. (19990803). Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro. : Antiviral research.

Chicago

Rübsamen-Waigmann H, Huguenel E, Shah A, Paessens A, Ruoff H J, von Briesen H, Immelmann A, Dietrich U and Wainberg M A. 19990803. Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro. : Antiviral research.

Harvard

Rübsamen-Waigmann H., Huguenel E., Shah A., Paessens A., Ruoff H. J., von Briesen H., Immelmann A., Dietrich U. and Wainberg M. A. (19990803). Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro. : Antiviral research.

MLA

Rübsamen-Waigmann H, Huguenel E, Shah A, Paessens A, Ruoff H J, von Briesen H, Immelmann A, Dietrich U and Wainberg M A. Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro. : Antiviral research. 19990803.